Search

Your search keyword '"Limongelli, G"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Limongelli, G" Remove constraint Author: "Limongelli, G" Topic medicine.disease Remove constraint Topic: medicine.disease
111 results on '"Limongelli, G"'

Search Results

1. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

2. Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET)

3. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry

4. Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction

5. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry

6. Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure

7. European Cardiomyopathy Pilot Registry : EURObservational Research Programme of the European Society of Cardiology

8. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

9. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey

10. Prognostic value of indeterminable anaerobic threshold in heart failure

11. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

12. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction

13. Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation

14. Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy

15. COVID-19 pandemia and inherited cardiomyopathies and channelopathies: A short term and long term perspective

16. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure

17. Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test

18. The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study

19. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

20. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumption

21. Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias

22. Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group

23. Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: application of metabolic exercise cardiac kidney indexes score

24. Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia

25. Diagnosis and Management of Cardiovascular Involvement in Fabry Disease

26. The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies

27. Bicuspid aortic valve identifying knowledge gaps and rising to the challenge from the international bicuspid aortic valve consortium (BAVCON)

28. Advanced Heart Failure in Special Population—Pediatric Age

29. Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers

30. Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy

31. Clinical Manifestations of 22q11.2 Deletion Syndrome

32. The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis

33. Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study

34. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis

35. The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy

36. The Role of Multimodality Imaging in Athlete’s Heart Diagnosis: Current Status and Future Directions

37. External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis

38. Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism

39. Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease

40. Editorial: Paediatric Cardiomyopathies

41. Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy

42. Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes

43. Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders

44. A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET)

45. Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve

46. Corrigendum to 'Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database' [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079))

47. Novel autophagic vacuolar myopathies: Phenotype and genotype features

48. Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry

49. The hospitalizations in hypertrophic cardiomyopathy: 'The dark side of the moon'

50. Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy

Catalog

Books, media, physical & digital resources